Trials / Sponsors / Teclison Ltd.
Teclison Ltd.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | TATE and Pembrolizumab (MK3475) in mCRC and NSCLC Colorectal Cancer; Lung Cancer | Phase 2 | 2021-05-20 |
| Terminated | TATE Versus TACE in Intermediate Stage HCC Carcinoma, Hepatocellular | Phase 2 | 2017-12-05 |
| Recruiting | Combination of TATE and PD-1 Inhibitor in Liver Cancer Hepatocellular Carcinoma, Gastric Cancer | Phase 2 | 2017-07-01 |
| Recruiting | Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic, Neuroendocrine Tumors | Phase 1 / Phase 2 | 2014-09-01 |